Antibiotic crisis deepens: How colonial-era drug monopolies and industrial neglect obscured penicillin’s origins—and why synthetic biology now risks repeating them
Original framing: “'Molecular movie' finally reveals how penicillin is made” — Phys.org
The penicillin story is a microcosm of colonial science’s ‘discovery’ of non-Western knowledge. In 1940, Pfizer’s mass production of penicillin in the U.S. was enabled by Indian farmers who grew *Penicillium* on rice bran—a practice derived from their own agricultural traditions. Meanwhile, the British government suppressed Indian research on antibiotics during WWII to maintain monopoly control. Today, the same dynamics play out with CRISPR and synthetic biology, where patents on ‘engineered’ microbes often build on Indigenous or Global South innovations without credit or compensation. The ‘molecular movie’ thus repeats a 200-year-old script: validate, patent, and profit from what was already known.
The ‘molecular movie’ of penicillin synthesis is not just a scientific milestone but a symptom of deeper structural failures: the erasure of Indigenous and Global South knowledge, the perpetuation of colonial-era monopolies, and the ecological myopia of industrial microbiology.
While Western labs celebrate their ability to ‘see’ the unseen, they ignore that the unseen was already known—and suppressed. The same corporations now controlling synthetic biology tools are heirs to the pharmaceutical empires that patented penicillin while denying credit to the farmers, healers, and scientists who made it possible. To break this cycle, solutions must center decolonized knowledge systems, ecological resilience, and legal frameworks that treat microbes as commons rather than commodities. The trickster here isn’t just the resistance bacteria but the system itself, which has turned life into a patentable resource while pretending to ‘discover’ what was always shared. The path forward lies in inverting the script: making synthetic biology serve the communities it once exploited, and ensuring that the next ‘molecular movie’ is co-written by those whose knowledge was stolen to make the first.